Table 6 Correlation of various genetic variants with IL-13 levels of cases and controls
From: Atopy in Kashmir-validation from a case control study with respect to IgE and Interleukin genes
Overall genotype/ | Cases | OR (95%CI) | P value | ||
|---|---|---|---|---|---|
IL-4 levels | Number (n) | Un (%) | D n (%) | ||
|  | n = 528 | 00 (00.0) | 528 (100.0) |  |  |
IL-4 RA (A148G) |  |  |  | 0.2 (0.01–4.1) | 0.4 |
 AA | 108 (20.4) | 00 | 108 | ||
 AG + GG | 420 (79.6) | 00 | 420 | ||
IL-4RA (A1902G) |  |  |  | 0.2 (0.01–3.8) | 0.3 |
 AA | 102 (19.3) | 00 | 102 | ||
 AG + GG | 426 (70.7) | 00 | 426 | ||
IL-4 70 bp VNTR |  |  |  | 0.2 (0.01–3.4) | 0.3 |
 2 repeats | 93 (17.6) | 00 | 93 | ||
 2/3 repeats | 435 (72.4) | 00 | 435 | ||
IL-13 (C1055T) |  |  |  | 0.6 (0.04–10.3) | 0.6 |
 CC | 207 (39.2) | 00 | 207 | ||
 CT + TT | 321 (60.8) | 00 | 321 | ||
IL-13 (A1512C) |  |  |  | 0.2 (0.01–3.7) | 0.3 |
 AA | 99 (18.7) | 00 | 99 | ||
 AC + CC | 429 (71.3) | 00 | 429 | ||
STAT-6 (G2964A) | Â | Â | Â | Â | Â |
 GG | 156 (29.5) | 00 | 156 | 0.4 (0.02–6.7) | 0.5 |
 GA + AA | 372 (70.5) | 00 | 372 |  |  |